| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Natera Inc (NASDAQ: NTRA)
NTRA Technical Analysis
4
| As on 9th Jun 2023 NTRA STOCK Price closed @ 48.38 and we RECOMMEND Sell for LONG-TERM with Stoploss of 49.25 & Strong Sell for SHORT-TERM with Stoploss of 72.59 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NTRASTOCK Price
| Open | 49.12 | Change | Price | % |
| High | 49.35 | 1 Day | -0.44 | -0.90 |
| Low | 47.65 | 1 Week | 1.30 | 2.76 |
| Close | 48.38 | 1 Month | -1.39 | -2.79 |
| Volume | 670100 | 1 Year | -43.61 | -47.41 |
| 52 Week High 95.64 | 52 Week Low 28.13 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NTRA Daily Charts |
NTRA Intraday Charts |
Whats New @ Bazaartrend |
NTRA Free Analysis |
|
|
NTRA Important Levels Intraday
| RESISTANCE | 51.66 |
| RESISTANCE | 50.61 |
| RESISTANCE | 49.96 |
| RESISTANCE | 49.31 |
| SUPPORT | 47.45 |
| SUPPORT | 46.80 |
| SUPPORT | 46.15 |
| SUPPORT | 45.10 |
NTRA Forecast April 2024
| 4th UP Forecast | 100.14 |
| 3rd UP Forecast | 83.54 |
| 2nd UP Forecast | 73.28 |
| 1st UP Forecast | 63.02 |
| 1st DOWN Forecast | 33.74 |
| 2nd DOWN Forecast | 23.48 |
| 3rd DOWN Forecast | 13.22 |
| 4th DOWN Forecast | -3.38 |
NTRA Weekly Forecast
| 4th UP Forecast | 67.96 |
| 3rd UP Forecast | 61.68 |
| 2nd UP Forecast | 57.80 |
| 1st UP Forecast | 53.92 |
| 1st DOWN Forecast | 42.84 |
| 2nd DOWN Forecast | 38.96 |
| 3rd DOWN Forecast | 35.08 |
| 4th DOWN Forecast | 28.80 |
NTRA Forecast2024
| 4th UP Forecast | 184.79 |
| 3rd UP Forecast | 141.04 |
| 2nd UP Forecast | 114 |
| 1st UP Forecast | 86.96 |
| 1st DOWN Forecast | 9.8 |
| 2nd DOWN Forecast | -17.24 |
| 3rd DOWN Forecast | -44.28 |
| 4th DOWN Forecast | -88.03 |
Natera Inc ( NASDAQ USA Symbol : NTRA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NTRA Business Profile
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California. Address: 201 Industrial Road, San Carlos, CA, United States, 94070
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service